[Consensus of Chinese experts on diagnosis and treatment of hemophilia(2013)]
- PMID: 23688764
- DOI: 10.3760/cma.j.issn.0253-2727.2013.05.020
[Consensus of Chinese experts on diagnosis and treatment of hemophilia(2013)]
Similar articles
-
[Consensus of Chinese experts on diagnosis and treatment of hemophilia].Zhonghua Xue Ye Xue Za Zhi. 2011 Mar;32(3):212-3. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 21535968 Chinese. No abstract available.
-
[Chinese expert consensus on the diagnosis and treatment of acquired hemophilia A].Zhonghua Xue Ye Xue Za Zhi. 2014 Jun;35(6):575-6. doi: 10.3760/cma.j.issn.0253-2727.2014.06.026. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24985192 Review. Chinese. No abstract available.
-
[Acquired hemophilia: update on diagnosis and treatment].Recenti Prog Med. 2011 Jul-Aug;102(7-8):286-9. doi: 10.1701/913.10046. Recenti Prog Med. 2011. PMID: 21779119 Italian.
-
The kaolin partial thromboplastin time (PTT) test: the normal value in 150 healthy chinese and the usefulness in the diagnosis and management of coagulopathies especially hemophilia.Taiwan Yi Xue Hui Za Zhi. 1970 Jun 28;69(6):311-26. Taiwan Yi Xue Hui Za Zhi. 1970. PMID: 5273022 No abstract available.
-
Role of molecular genetics in hemophilia: from diagnosis to therapy.Semin Thromb Hemost. 2012 Feb;38(1):64-78. doi: 10.1055/s-0031-1300953. Epub 2012 Feb 7. Semin Thromb Hemost. 2012. PMID: 22314605 Review.
Cited by
-
Optimized human factor IX expression cassettes for hepatic-directed gene therapy of hemophilia B.Front Med. 2015 Mar;9(1):90-9. doi: 10.1007/s11684-015-0390-2. Epub 2015 Feb 7. Front Med. 2015. PMID: 25663062
-
Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A.Clin Appl Thromb Hemost. 2021 Jan-Dec;27:1076029621989811. doi: 10.1177/1076029621989811. Clin Appl Thromb Hemost. 2021. PMID: 33587652 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Medical